Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs
Yıl: 2022 Cilt: 11 Sayı: 1 Sayfa Aralığı: 180 - 190 Metin Dili: İngilizce DOI: 10.5505/ktd.2022.43926 İndeks Tarihi: 21-06-2022
Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs
Öz: Objective: The purpose of this study was to determine the prevalence of anxiety due to Coronavirus disease-2019 (COVID-19)
pandemic in patients with rheumatic and musculoskeletal diseases (RMDs) who used immunosuppressive drugs during the
initial stage of the COVID-19 pandemic and to identify the risk and protective factors that cause anxiety.
Method: A total of 145 patients with RMDs who used regular immunosuppressive drugs and 95 healthy controls were
included. An anonymous survey comprising questions regarding the COVID-19 pandemic was used, and the Beck anxiety
inventory (BAI).
Results: About 42.1% patients reported that the epidemic caused concern due to the drug they were using, 33.8% rated their
concerns as moderate and severe. According to the BAI scores, 16.5% patients had moderate to severe anxiety symptoms;
and comparison of the groups showed that the anxiety level of the patient group was significantly higher (38.6% vs. 18.9%,
p=0.001). Female had more anxiety symptoms in both groups (p<0.005). In addition, anxiety was lower in patients with higher
education levels (p=0.039).
Conclusion: : It should be ensured that patients in the high-risk group are not provided false information, the patients
are individually informed, and they trust the treatment team. Providing online or smartphone-based psychoeducation and
psychological interventions may be considered for these patients with high anxiety levels.
Anahtar Kelime: İmmünsüpresif İlaç Kullanan Romatoloji Hastalarında COVID-19 Pandemisinin Anksiyete Üzerine Etkisi
Öz: Giriş: : Bu çalışmanın amacı, Coronavirus hastalığı-2019 (COVID-19) salgınının ilk aşamasında romatizmal ve kas-iskelet
sistemi hastalıkları (RMDs) olan ve immunsupresif ilaç kullanan hastalarda COVID-19 salgınına bağlı anksiyete yaygınlığını
tespit etmek ve anksiyeteye sebep olan risk ve koruyucu faktörleri tanımlamaktır.
Yöntem: 18 yaşından büyük, RMDs’i olan ve düzenli immunsupresif ilaç kullanan 145 hasta ve 95 sağlıklı kontrol çalışmaya
dahil edildi. COVID-19 salgını ile ilgili soruları içeren anonim bir anket ve katılımcıların anksiyete düzeylerini ölçmek için Beck
anksiyete envanteri (BAI) kullanıldı. Demografik veriler, mevcut RMDs’i, kullandığı immunsupresif ilaç, COVID-19 hakkında
bilgi ve endişeler, COVID-19 hakkındaki bilgileri nereden öğrendiği gibi ek bilgiler toplandı.
Bulgular: Hastaların %42,1’i kullandıkları ilaç nedeniyle salgının endişe yarattığını bildirdi ve hastaların %33,8’i endişelerini
orta ve şiddetli olarak derecelendirdiler. Hastaların BAI skorları 4 (0-52) ve sağlıklı kontrollerin BAI skorları 3 (0-18) olarak
saptandı. BAI skorlarına göre hastaların %16,5’i orta ile şiddetli anksiyete belirtileri göstermiştir. İmmunsupresif ilaç kullanan
hastaların %38,6’sında anksiyete saptanırken kontrol grubunun %18,9’unda anksiyete mevcuttu. Gruplar karşılaştırıldığında
hasta grubunun anksiyetesi anlamlı yüksek saptandı (p=0.001). Hasta ve kontrol gruplarında kadın cinsiyet daha fazla anksiyete
belirtileri göstermektedir (p<0.005). Ayrıca hasta grubunda eğitim düzeyi yüksek olanlarda anksiyete daha düşük saptandı
(p=0.039).
Sonuç: Kadın cinsiyet ve immunsupresif ilaç kullanan hastalarda anksiyete düzeyleri daha yüksek saptanmıştır. Bu süreçte riskli
grupta yer alan bu hastaların yanlış bilgilerden kaçınmasını sağlamalı, hastalar tek tek bilgilendirilerek tedavi ekibine güvenmeleri
sağlanmalıdır. Anksiyeteleri yüksek olan bu hasta grubu için çevrimiçi veya akıllı telefon tabanlı psikoeğitim ve psikolojik
müdahaleler sağlanması düşünebilir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Song J, Kang S, Choi SW, Seo KW, Lee S, So MW, et al. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs. Rheumatol Int. 2020;40(6):991-5.
- 2. Organization WH. Coronavirus disease 2019 (COVID-19) : situation report, 51. 2020.
- 3. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470-3.
- 4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.
- 5. Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R, et al. The rate of underascertainment of novel coronavirus (2019-nCoV) infection: Estimation using Japanese passengers data on evacuation flights. Multidisciplinary Digital Publishing Institute; 2020.
- 6. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020.
- 7. Hall RC, Hall RC, Chapman MJ. The 1995 Kikwit Ebola outbreak: lessons hospitals and physicians can apply to future viral epidemics. Gen Hosp Psychiatry. 2008;30(5):446-52.
- 8. Peng EY, Lee MB, Tsai ST, Yang CC, Morisky DE, Tsai LT, et al. Population-based postcrisis psychological distress: an example from the SARS outbreak in Taiwan. J Formos Med Assoc. 2010;109(7):524-32.
- 9. Organization WH. Mental health and psychosocial considerations during the COVID-19 outbreak, 18 March 2020. World Health Organization; 2020.
- 10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
- 11. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74.
- 12. Rubin GJ, Wessely S. The psychological effects of quarantining a city. Bmj. 2020;368.
- 13. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in china. International Journal of Environmental Research and Public Health. 2020;17(5):1729.
- 14. Rheumatism TELA. EULAR Guidance for patients COVID-19 outbreak 2020 https://www.eular.org/eular_guidance_for_ patients_covid19_outbreak.cfm.
- 15. Rubin GJ, Potts HW, Michie S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: resultsfrom 36 national telephone surveysin the UK. Health Technol Assess. 2010;14(34):183- 266.
- 16. Leung GM, Quah S, Ho LM, Ho SY, Hedley AJ, Lee HP, et al. Community psychobehavioural surveillance and related impact on outbreak control in Hong Kong and Singapore during the SARS epidemic. Hong Kong Med J. 2009;15 Suppl 9:30-4.
- 17. Ulusoy M, Sahin NH, Erkmen H. The Beck anxiety inventory: psychometric properties. Journal of cognitive psychotherapy. 1998;12(2):163-72.
- 18. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. Journal of consulting and clinical psychology. 1988;56(6):893.
- 19. Taylor S. The Psychology of Pandemics: Preparing for the Next Global Outbreak of Infectious Disease: Cambridge Scholars Publishing; 2019.
- 20. Taylor S, Asmundson GJ. Treating health anxiety: A cognitive-behavioral approach: Guilford Press; 2004.
- 21. Patel A, Jernigan DB. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(5):140-6.
- 22. Remes O, Brayne C, Van Der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and behavior. 2016;6(7):e00497.
- 23. Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476-93.
- 24. Zhang MW, Ho CS, Ho R. Methodology of development and students’ perceptions of a psychiatry educational smartphone application. Technology and Health Care. 2014;22(6):847- 55.
- 25. Do TTT, Le MD, Van Nguyen T, Tran BX, Le HT, Nguyen HD, et al. Receptiveness and preferences of health-related smartphone applications among Vietnamese youth and young adults. BMC Public Health. 2018;18(1):764.
- 26. Lisitsyna TA, Veltishchev DY, Seravina OF, Kovalevskaya OB, Starovoytova MN, Desinova OV, et al. Comparative analysis of anxietydepressive spectrum disorders in patients with rheumatic diseases. Ter Arkh. 2018;90(5):30-7.
- 27. Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K, et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int. 2011;31(6):795-800.
- 28. Isik A, Koca SS, Ozturk A, Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol. 2007;26(6):872-8.
- 29. Xu X, Shen B, Zhang A, Liu J, Da Z, Liu H, et al. Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis. Patient preference and adherence. 2016;10:879.
- 30. Yilmaz-Oner S, Oner C, Dogukan FM, Moses TF, Demir K, Tekayev N, et al. Anxiety and depression predict quality of life in Turkish patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2015;33(3):360-5.
| APA | DURAN T, Açıkgöz S, Gürbüz C, UÇAR A, BİLGE G, Ozgen M (2022). Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . , 180 - 190. 10.5505/ktd.2022.43926 |
| Chicago | DURAN Tuğba İZCİ,Açıkgöz Seyyid Bilal,Gürbüz Cemal,UÇAR Ayşegül,BİLGE Gökhan Yavuz,Ozgen Metin Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . (2022): 180 - 190. 10.5505/ktd.2022.43926 |
| MLA | DURAN Tuğba İZCİ,Açıkgöz Seyyid Bilal,Gürbüz Cemal,UÇAR Ayşegül,BİLGE Gökhan Yavuz,Ozgen Metin Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . , 2022, ss.180 - 190. 10.5505/ktd.2022.43926 |
| AMA | DURAN T,Açıkgöz S,Gürbüz C,UÇAR A,BİLGE G,Ozgen M Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . . 2022; 180 - 190. 10.5505/ktd.2022.43926 |
| Vancouver | DURAN T,Açıkgöz S,Gürbüz C,UÇAR A,BİLGE G,Ozgen M Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . . 2022; 180 - 190. 10.5505/ktd.2022.43926 |
| IEEE | DURAN T,Açıkgöz S,Gürbüz C,UÇAR A,BİLGE G,Ozgen M "Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs ." , ss.180 - 190, 2022. 10.5505/ktd.2022.43926 |
| ISNAD | DURAN, Tuğba İZCİ vd. "Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs ". (2022), 180-190. https://doi.org/10.5505/ktd.2022.43926 |
| APA | DURAN T, Açıkgöz S, Gürbüz C, UÇAR A, BİLGE G, Ozgen M (2022). Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . Kocaeli Tıp Dergisi, 11(1), 180 - 190. 10.5505/ktd.2022.43926 |
| Chicago | DURAN Tuğba İZCİ,Açıkgöz Seyyid Bilal,Gürbüz Cemal,UÇAR Ayşegül,BİLGE Gökhan Yavuz,Ozgen Metin Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . Kocaeli Tıp Dergisi 11, no.1 (2022): 180 - 190. 10.5505/ktd.2022.43926 |
| MLA | DURAN Tuğba İZCİ,Açıkgöz Seyyid Bilal,Gürbüz Cemal,UÇAR Ayşegül,BİLGE Gökhan Yavuz,Ozgen Metin Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . Kocaeli Tıp Dergisi, vol.11, no.1, 2022, ss.180 - 190. 10.5505/ktd.2022.43926 |
| AMA | DURAN T,Açıkgöz S,Gürbüz C,UÇAR A,BİLGE G,Ozgen M Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . Kocaeli Tıp Dergisi. 2022; 11(1): 180 - 190. 10.5505/ktd.2022.43926 |
| Vancouver | DURAN T,Açıkgöz S,Gürbüz C,UÇAR A,BİLGE G,Ozgen M Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs . Kocaeli Tıp Dergisi. 2022; 11(1): 180 - 190. 10.5505/ktd.2022.43926 |
| IEEE | DURAN T,Açıkgöz S,Gürbüz C,UÇAR A,BİLGE G,Ozgen M "Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs ." Kocaeli Tıp Dergisi, 11, ss.180 - 190, 2022. 10.5505/ktd.2022.43926 |
| ISNAD | DURAN, Tuğba İZCİ vd. "Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs ". Kocaeli Tıp Dergisi 11/1 (2022), 180-190. https://doi.org/10.5505/ktd.2022.43926 |
